LUKING; Angelika

Patent Applications and Registrations

Patent applications and USPTO patent grants for LUKING; Angelika.The latest application filed is for "marker sequences for diagnosing and stratifying sle patients".

Company Profile

2.5.21

LUKING; Angelika - Bochum DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Marker Sequences For Diagnosing And Stratifying Sle Patients App 20210055296 - LUKING; Angelika ; et al.	2021-02-25
Marker Sequences For Diagnosing And Stratifying Systemic Sclerosis Patients App 20210003590 - BUDDE; Petra ; et al.	2021-01-07
Marker sequences for diagnosing and stratifying SLE patients Grant 10,746,735 - Luking , et al. A	2020-08-18
Marker sequences for the diagnosis and stratification of systemic sclerosis patients Grant 10,677,795 - Budde , et al.	2020-06-09
Marker sequences for diagnosing and stratifying systemic sclerosis patients Grant 10,571,477 - Budde , et al. Feb	2020-02-25
Marker Sequences For Managing The Therapy Of Rheumatoid Arthritis Patients App 20190128884 - BUDDE; Petra ; et al.	2019-05-02
Marker Sequences For Rheumatoid Arthritis App 20190120834 - LUKING; Angelika ; et al.	2019-04-25
Method for the diagnosis of neuromyelitis optica Grant 10,036,746 - Gohler , et al. July 31, 2	2018-07-31
Marker Sequences For The Diagnosis And Stratification Of Systemic Sclerosis Patients App 20180017554 - BUDDE; Petra ; et al.	2018-01-18
Marker Sequences For Diagnosing And Stratifying Systemic Sclerosis Patients App 20170199202 - BUDDE; Petra ; et al.	2017-07-13
Method For The Diagnosis Of Neuromyelitis Optica App 20170115288 - Gohler; Heike ; et al.	2017-04-27
Marker Sequences For Diagnosing And Stratifying Sle Patients App 20170074875 - LUKING; Angelika ; et al.	2017-03-16
Method for the diagnosis of neuromyelitis optica Grant 9,588,115 - Gohler , et al. March 7, 2	2017-03-07
Marker Sequences For Rheumatoid Arthritis And Use Thereof App 20170009300 - Beator; Jens ; et al.	2017-01-12
Method For The Diagnosis Of Neuromyelitis Optica App 20160054318 - GOHLER; Heike ; et al.	2016-02-25
Marker Sequences For Rheumatoid Arthritis App 20150293120 - LUKING; Angelika ; et al.	2015-10-15
Method For Identifying Marker Sequences For Gynaecological Malignant Tumours App 20150177247 - LUKING; ANGELIKA ; et al.	2015-06-25
Marker Sequences For Rheumatoid Arthritis And Use Thereof App 20150087548 - Beator; Jens ; et al.	2015-03-26
Marker Sequences For Multiple Sclerosis And Use Thereof App 20150024962 - Beator; Jens ; et al.	2015-01-22
Marker Sequences For Breast Cancer And The Use Thereof App 20140371098 - Luking; Angelika ; et al.	2014-12-18
Marker Sequence For Neurodegenerative Diseases And The Use Thereof App 20110184375 - Gohler; Heike ; et al.	2011-07-28
Protein Biochip For The Differential Screening Of Protein-protein Interactions App 20100331201 - Mullner; Stefan ; et al.	2010-12-30
Marker Sequences For Multiple Sclerosis And Use Thereof App 20100280224 - Beator; Jens ; et al.	2010-11-04
Marker Sequences For Rheumatoid Arthritis And Use Thereof App 20100261881 - Beator; Jens ; et al.	2010-10-14
Method For Immunoadsorption By Means Of Autoanitgens App 20090246203 - Luking; Angelika ; et al.	2009-10-01
Protein-biochip for validating binding agents App 20090124509 - Weingarten; Petra ; et al.	2009-05-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.